ATM and cancer: It can therefore be expected that the inhibition of ATM impairs multiple mechanisms of survival in cancer cells, which are not limited to metabolic adaptation to cell stress, or to drug internalization, but which also include escape from the immune system and from host tissue biological surveillance.